Javascript must be enabled to continue!
Japanese cedar pollinosis and HLA‐DP5
View through CrossRef
Japanese cedar pollinosis is a type I allergic disease caused by Japanese cedar (Cryptomeria japonica) pollen. We investigated the association between the disease and HLA class II alleles by HLA‐DNA typing using a PCR‐SSOP method and found that the frequency of HLA‐DP5 (DPA1*02022 and DPB1*0501) was significantly increased in the patients. To investigate whether the HLA‐DP5 molecule is directly involved in the pathogenesis of the disease, Japanese cedar pollen antigen (CPAg)‐specific T cell lines were established from 3 patients who possessed HLA‐DP5 (DPA1*02022/DPB1*0501). By using these CPAg‐specific T cell lines and HLA class II‐expressing L‐cell transfectants, we found that disease‐associated HLA‐DP5 restricted T cells specific for CPAg existed in the patients. Furthermore, among 38 synthesized overlapping peptides spanning the entire length of one of the major Japanese cedar pollen allergens, Cry j 1, an immunodominant peptide which induced HLA‐DP5 restricted Th2 was identified. These observations suggest that the HLA‐DP5 may be involved, at least in part, in the pathogenesis, by helping the IgE antibody production against CPAg.
Title: Japanese cedar pollinosis and HLA‐DP5
Description:
Japanese cedar pollinosis is a type I allergic disease caused by Japanese cedar (Cryptomeria japonica) pollen.
We investigated the association between the disease and HLA class II alleles by HLA‐DNA typing using a PCR‐SSOP method and found that the frequency of HLA‐DP5 (DPA1*02022 and DPB1*0501) was significantly increased in the patients.
To investigate whether the HLA‐DP5 molecule is directly involved in the pathogenesis of the disease, Japanese cedar pollen antigen (CPAg)‐specific T cell lines were established from 3 patients who possessed HLA‐DP5 (DPA1*02022/DPB1*0501).
By using these CPAg‐specific T cell lines and HLA class II‐expressing L‐cell transfectants, we found that disease‐associated HLA‐DP5 restricted T cells specific for CPAg existed in the patients.
Furthermore, among 38 synthesized overlapping peptides spanning the entire length of one of the major Japanese cedar pollen allergens, Cry j 1, an immunodominant peptide which induced HLA‐DP5 restricted Th2 was identified.
These observations suggest that the HLA‐DP5 may be involved, at least in part, in the pathogenesis, by helping the IgE antibody production against CPAg.
Related Results
High Resolution HLA-A, HLA-B, and HLA-C Allele Frequencies in Romanian Hematopoietic Stem Cell Donors
High Resolution HLA-A, HLA-B, and HLA-C Allele Frequencies in Romanian Hematopoietic Stem Cell Donors
The HLA genes are associated with various autoimmune pathologies, with the control of the immune response also being significant in organs and cells transplantation. The aim of the...
Diversity of HLA Class I and II Genes in the North Indian Population
Diversity of HLA Class I and II Genes in the North Indian Population
Introduction: Numerous studies have concentrated on specific populations to explore the extensive polymorphism of class I and II HLA genes. This genetic diversity is crucial for va...
CD34 negative HLA‐DR negative acute myeloid leukaemia: A higher association with NPM1 and FLT3‐ITD mutations
CD34 negative HLA‐DR negative acute myeloid leukaemia: A higher association with NPM1 and FLT3‐ITD mutations
AbstractIntroductionCD34 and HLA‐DR negativity is often used as a characteristic immunophenotypic feature of acute promyelocytic leukaemia (APL) that differentiates APL from other ...
Abstract 1658: Gemcitabine impacts expression of antigen presentation proteins by pancreatic cancer cells
Abstract 1658: Gemcitabine impacts expression of antigen presentation proteins by pancreatic cancer cells
Abstract
Background: Pancreatic adenocarcinoma is one of the deadliest type of cancers with a 5-year overall survival rate of 10%. A standard chemotherapy approach f...
HLA Gene Polymorphisms in Romanian Patients with Chronic Lymphocytic Leukemia
HLA Gene Polymorphisms in Romanian Patients with Chronic Lymphocytic Leukemia
Background and Objectives. Numerous genome-wide association studies have highlighted that chronic lymphocytic leukemia (CLL) is a lymphoproliferative disorder with an important gen...
Immunogenetic Background of Chronic Lymphoproliferative Disorders in Romanian Patients—Case Control Study
Immunogenetic Background of Chronic Lymphoproliferative Disorders in Romanian Patients—Case Control Study
Background and Objectives: The implications of the genetic component in the initiation and development of chronic lymphoproliferative disorders have been the subject of intense res...
CD Markers and HLA Expression in Chronic Lymphocytic Leukemia Patients: correlations and clinical relevance
CD Markers and HLA Expression in Chronic Lymphocytic Leukemia Patients: correlations and clinical relevance
Chronic lymphocytic leukemia (CLL) is a distinct category of lymphoproliferative disorder characterized by the clonal expansion of mature B cells, followed by their accumulation in...
The Impact of Anti-HLA Antibodies on the Prognosis of Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome
The Impact of Anti-HLA Antibodies on the Prognosis of Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome
Objective To investigate the risk factors of positive anti-HLA antibodies in myelodysplastic syndrome (MDS) patients and gain insights into the impact of anti-HLA antibodies in all...

